Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -51.20%-31.26K | 74.10%-48.16K | 104.00%805 | -23.97%-456.24K | -315.64%-229.5K | 53.61%-20.68K | -49.74%-185.94K | 86.03%-20.12K | 28.23%-368.02K | 75.13%-55.22K |
| Net income from continuing operations | 84.11%-34.4K | -458.97%-105.58K | 42.16%-95.25K | -5,066.99%-633.99K | -179.38%-282.2K | -70.07%-216.52K | 132.40%29.41K | -32.13%-164.68K | 101.74%12.76K | 213.34%355.49K |
| Operating gains losses | ---- | ---- | ---- | ---57K | --0 | --0 | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | --0 | --126.57K | --14.07K | ---- | ---- | --75K | --0 | --0 |
| Remuneration paid in stock | ---- | ---- | ---- | --107.68K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -506.38%-522K | ---- |
| Change In working capital | -20.64%66.14K | 168.88%57.42K | 38.08%96.05K | -99.65%500 | -162.04%-69.05K | 0.72%83.34K | -149.52%-83.36K | 458.17%69.56K | 135.92%141.21K | 514.17%111.3K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.99%9.65K | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 728.18%5.53K | ---- |
| -Change in payables and accrued expense | 7.08%64.9K | 183.22%48.09K | 49.18%97.36K | -78.50%27.1K | -138.53%-40.99K | 4.61%60.61K | -232.51%-57.78K | 411.75%65.26K | 358.93%126.03K | 561.07%106.4K |
| -Change in other current assets | -94.54%1.24K | 136.48%9.33K | -130.32%-1.3K | -275.23%-26.6K | -673.33%-28.06K | -8.36%22.73K | -59.54%-25.57K | 184.46%4.3K | --15.18K | --4.89K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -51.20%-31.26K | 74.10%-48.16K | 104.00%805 | -23.97%-456.24K | -315.64%-229.5K | 53.61%-20.68K | -49.74%-185.94K | 86.03%-20.12K | 28.23%-368.02K | 75.13%-55.22K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 18.48K | 128.28K | 128.28K | 0 | 0 | 0 | 0 | |
| Net investment purchase and sale | --0 | --0 | --18.48K | --128.28K | --128.28K | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --18.48K | --128.28K | --128.28K | --0 | --0 | --0 | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 376.8K | 102.43K | 0 | 178.38K | 96K | 0 | 0 |
| Net common stock issuance | --0 | ---- | ---- | --305K | --0 | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --102.43K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | ---30.63K | --0 | --0 | ---126.63K | --96K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --376.8K | --102.43K | --0 | --178.38K | --96K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -43.91%61.76K | -6.58%109.92K | 116.90%90.63K | -89.80%41.79K | -7.81%89.42K | -22.23%110.1K | -55.72%117.67K | -89.80%41.79K | -7.98%409.81K | 17.04%97K |
| Current changes in cash | -51.20%-31.26K | -536.28%-48.16K | -74.59%19.29K | 113.27%48.85K | 102.19%1.21K | 53.61%-20.68K | 93.90%-7.57K | 152.67%75.88K | -935.61%-368.02K | -116.89%-55.22K |
| End cash Position | -65.90%30.5K | -43.91%61.76K | -6.58%109.92K | 116.90%90.63K | 116.90%90.63K | -7.81%89.42K | -22.23%110.1K | -55.72%117.67K | -89.80%41.79K | -89.80%41.79K |
| Free cash from | -51.20%-31.26K | 74.10%-48.16K | 104.00%805 | -23.97%-456.24K | -315.64%-229.5K | 53.61%-20.68K | -49.74%-185.94K | 86.03%-20.12K | 28.23%-368.02K | 63.27%-55.22K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.